£520.00

The 2023-2028 Outlook for Chlamydia Infection Diagnostics and Therapeutics in the United States

Price data last checked 75 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 16 days • 16 data points (No recent data available)

Historical
Generating forecast...
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 26 January 2026 29 January 2026 02 February 2026 06 February 2026 10 February 2026

Price Distribution

Price distribution over 16 days • 1 price levels

Days at Price
16 days 0 4 8 12 16 £520 Days at Price

Price Analysis

Most common price: £520 (16 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 16 days

Product Specifications

Format
Paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Chlamydia Infection Diagnostics in the United States
99% match

The 2023-2028 Outlook for Chlamydia Infection Diagnostics in the United States

£520.00 12 Feb 2026
The 2023-2028 Outlook for Chlamydia Infection Diagnostics and Therapeutics in India
98% match

The 2023-2028 Outlook for Chlamydia Infection Diagnostics and Therapeutics in India

£515.00 15 Feb 2026
The 2023-2028 Outlook for Chlamydia Infection Diagnostics in India
98% match

The 2023-2028 Outlook for Chlamydia Infection Diagnostics in India

£515.00 07 Jan 2026
The 2023-2028 Outlook for Gonorrhea Therapeutics in the United States
97% match

The 2023-2028 Outlook for Gonorrhea Therapeutics in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Chlamydia Infection Diagnostics and Therapeutics in China
97% match

The 2023-2028 Outlook for Chlamydia Infection Diagnostics and Therapeutics in China

£495.00 26 Jan 2026
The 2023-2028 Outlook for Chlamydia Infection Diagnostics in China
96% match

The 2023-2028 Outlook for Chlamydia Infection Diagnostics in China

£495.00 22 Jan 2026
The 2023-2028 Outlook for Gram-Positive Bacterial Infections in the United States
96% match

The 2023-2028 Outlook for Gram-Positive Bacterial Infections in the United States

£520.00 27 Jan 2026
The 2023-2028 Outlook for Viral Infections in the United States
96% match

The 2023-2028 Outlook for Viral Infections in the United States

£520.00 23 Jan 2026
The 2023-2028 Outlook for Chlamydia Infection Diagnostics and Therapeutics in Japan
96% match

The 2023-2028 Outlook for Chlamydia Infection Diagnostics and Therapeutics in Japan

£495.00 16 Dec 2025
The 2023-2028 Outlook for Clinical Chemistry Analyzers in the United States
96% match

The 2023-2028 Outlook for Clinical Chemistry Analyzers in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Chlamydia Infection Diagnostics in Japan
96% match

The 2023-2028 Outlook for Chlamydia Infection Diagnostics in Japan

£495.00 10 Feb 2026
The 2023-2028 Outlook for Tropical Disease Testing Products in the United States
96% match

The 2023-2028 Outlook for Tropical Disease Testing Products in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Bloodstream Infection Testing in the United States
96% match

The 2023-2028 Outlook for Bloodstream Infection Testing in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Herpes Simplex Virus Infections in the United States
96% match

The 2023-2028 Outlook for Herpes Simplex Virus Infections in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Antiviral Drugs in the United States
96% match

The 2023-2028 Outlook for Antiviral Drugs in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Anti-Malarial Drugs in the United States
96% match

The 2023-2028 Outlook for Anti-Malarial Drugs in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Pseudomonas Aeruginosa Infection Treatments in the United States
96% match

The 2023-2028 Outlook for Pseudomonas Aeruginosa Infection Treatments in the United States

£520.00 16 Feb 2026
The 2023-2028 Outlook for Antiseptics and Disinfectants in the United States
96% match

The 2023-2028 Outlook for Antiseptics and Disinfectants in the United States

£520.00 11 Feb 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States
96% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States

£520.00 21 Jan 2026
The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in the United States
96% match

The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in the United States

£520.00 23 Jan 2026
The 2023-2028 Outlook for E. Coli Testing in the United States
96% match

The 2023-2028 Outlook for E. Coli Testing in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Condoms in the United States
96% match

The 2023-2028 Outlook for Condoms in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Contraceptive Drugs in the US
96% match

The 2023-2028 Outlook for Contraceptive Drugs in the US

£520.00 25 Feb 2026
The 2023-2028 Outlook for Gonorrhea Therapeutics in India
96% match

The 2023-2028 Outlook for Gonorrhea Therapeutics in India

£515.00 09 Feb 2026